Editorial: Advances in hypersensitivity drug reactions

Curr Opin Allergy Clin Immunol. 2020 Aug;20(4):331-332. doi: 10.1097/ACI.0000000000000649.

Authors

Miguel Blanca¹, Paul Whitaker²

Affiliations

¹ Allergy Service, Hospital Infanta Leonor, Madrid, Spain.
² Department of Respiratory Medicine, Bradford Teaching Hospitals NHS Foundation Trust, UK.

PMID: 32590500
DOI: 10.1097/ACI.0000000000000649

No abstract available

Publication types

Editorial
Introductory Journal Article

MeSH terms

Anti-Allergic Agents / administration & dosage*
Anti-Bacterial Agents / adverse effects
Desensitization, Immunologic / methods
Diagnosis, Differential
Drug Hypersensitivity / diagnosis
Drug Hypersensitivity / immunology
Drug Hypersensitivity / prevention & control*
Glucocorticoids / adverse effects
Humans
Immunoglobulin E / immunology*
Immunoglobulin E / metabolism
Omalizumab / administration & dosage
T-Lymphocytes, Cytotoxic / drug effects
T-Lymphocytes, Cytotoxic / immunology

Substances

Anti-Allergic Agents
Anti-Bacterial Agents
Glucocorticoids
Omalizumab
Immunoglobulin E